Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (32927)	2/23/2009 1:16:25 PM
From: E_K_S	Read Replies (1) \| Respond to of 78451

Hi Paul - I am looking at LLY as a long term value buy. I think you bought some shares at current levels late last year. However since then, LLY has announced that they are involved with a class action which could be as high as $2 Billion to settle. Have you changed your opinion on this stock? Lilly May Spend $2 Billion More on Zyprexa Lawsuits (Update2) bloomberg.com GSK is my alternative choice. I would be adding to a current position for GSK but LLY would be a starter position. EKS